D. Stein

Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study

R. Haubrich, M. Kozal, K. Tashima, 2014, The Journal of infectious diseases.

The Effect of the Interaction of Acyclovir with Zidovudine on Progression to AIDS and Survival: Analysis of Data in the Multicenter AIDS Cohort Study

J. Phair, R. Detels, A. Saah, 1994, Annals of Internal Medicine.

Phase I Studies of Hypericin, the Active Compound in St. John's Wort, as an Antiretroviral Agent in HIV-Infected Adults: AIDS Clinical Trials Group Protocols 150 and 258

C. Crumpacker, J. Holden-Wiltse, F. Valentine, 1999, Annals of Internal Medicine.

The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group.

J. Phair, M. Hirsch, S. Lagakos, 1994, JAMA.

Effects of zidovudine therapy in minority and other subpopulations with early HIV infection.

S. Lagakos, P. Volberding, M. Fischl, 1991, JAMA.